The supplement industry has attempted to replace creatine monohydrate at least five times in the past 20 years. Buffered creatine, creatine ethyl ester, creatine citrate, liquid creatine, time-release creatine. Every successor product has claimed superior bioavailability, reduced side effects, or better absorption. Not one has outperformed monohydrate in a head-to-head clinical trial.
This is not ambiguous. It is documented with peer-reviewed data — and yet the premium-priced alternatives continue to dominate shelf space in sports nutrition retailers.
---
Creatine Ethyl Ester (CrEE) was marketed on the premise that esterification would improve membrane permeability and absorption compared to monohydrate. The theoretical rationale had some plausibility. The clinical reality did not support it.
Spillane and colleagues (2009) conducted a randomised, double-blind trial comparing CrEE to monohydrate over 48 days of resistance training. Muscle creatine content (measured by biopsy) was significantly lower in the CrEE group than the monohydrate group at the end of the study. The reason: creatine ethyl ester is rapidly hydrolysed in the acidic environment of the stomach to creatinine — the waste product — before it can be absorbed intact. The ester bond is cleaved by serum esterases and stomach acid, delivering creatinine to the bloodstream rather than creatine. This is not a bioavailability advantage — it is a delivery failure.
---
Kre-Alkalyn — marketed as "buffered" creatine with a higher pH (pH 12) to prevent breakdown in the stomach — is perhaps the most persistently promoted creatine alternative. The implicit claim is that standard monohydrate degrades to creatinine in stomach acid before absorption, and Kre-Alkalyn's alkaline buffering prevents this.
Greenhaff (1994) established that creatine monohydrate is in fact stable at gastric pH for the typical 90-120 minute gastric transit time. The degradation rate at pH 1–2 over 60 minutes is minimal. The pH-instability premise underpinning Kre-Alkalyn's marketing is not consistent with the pharmacokinetic data on monohydrate.
Jagim and colleagues (2012) tested this directly in a head-to-head RCT: Kre-Alkalyn at the recommended dose vs monohydrate at equivalent creatine content. Muscle creatine loading was identical between groups. Strength gains were identical. The only difference was the price — Kre-Alkalyn costs significantly more per gram of creatine delivered.
---
Creatine citrate and creatine malate are more soluble in water than monohydrate, making them more palatable in solution. Solubility does not equate to bioavailability at the intestinal absorption level, where the SLC6A8 creatine transporter governs uptake. Muscle creatine loading with citrate or malate forms, when controlling for equivalent creatine doses, does not exceed monohydrate in published trials.
The SLC6A8 transporter is the rate-limiting factor, not gastric solubility or ester stability. This transporter operates via Na⁺/Cl⁻ cotransport and has a defined maximum transport capacity that can be saturated regardless of the molecular form used to deliver creatine to the intestinal lumen.
---
The evidence-based recommendation remains: creatine monohydrate, specifically the micronised form for improved solubility, at either a loading dose (20g/day for 5–7 days) or a maintenance protocol (3–5g/day for 28+ days). The loading protocol saturates muscle phosphocreatine stores faster; the maintenance protocol reaches the same endpoint with fewer GI effects for those who find high acute doses cause gastric discomfort.
For athletes calculating whether to use a loading or maintenance protocol — and ensuring the dose is matched to body mass — the personalised loading calculator at winsport.uk/tools/nutrition/creatine-loading-calculator provides evidence-based dose recommendations based on lean body mass, with both protocols presented alongside expected PCr saturation timelines.
Have you ever paid a premium for a "superior" creatine formulation that turned out to perform no better than monohydrate?